CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues:
Total revenues	$ 28,271	$ 164	$ 29,457	$ 214
Operating expenses:
Cost of goods sold	456		473
Research and development	20,153	29,426	80,305	92,135
Selling, general and administrative	35,877	18,350	102,361	47,734
Total operating expenses	56,486	47,776	183,139	139,869
Loss from operations	(28,215)	(47,612)	(153,682)	(139,655)
Interest income	4,877	4,965	14,448	13,556
Interest expense	(3,046)	(2,066)	(9,798)	(5,991)
Other income and (expense), net	(63)	(92)	(188)	(64)
Net loss	$ (26,447)	$ (44,805)	$ (149,220)	$ (132,154)
Basic net loss per share	$ (0.04)	$ (0.08)	$ (0.23)	$ (0.23)
Diluted net loss per share	$ (0.04)	$ (0.08)	$ (0.23)	$ (0.23)
Shares used in computing basic net loss per share	662,158,182	579,508,305	639,933,612	562,445,577
Shares used in computing diluted net loss per share	662,158,182	579,508,305	639,933,612	562,445,577
Product Revenue, Net
Revenues:
Total revenues	$ 28,209		$ 28,989
Royalties
Revenues:
Total revenues	$ 62	$ 164	$ 468	$ 214

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

Name:	us-gaap_EarningsPerShareBasic
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.